Histogenics Closes $30.0 Million Private Placement
Histogenics closed its previously-announced US $30.0MM private placement. Funds will support development of NeoCart® novel cartilage repair therapy, including completion of the...
Histogenics closed its previously-announced US $30.0MM private placement. Funds will support development of NeoCart® novel cartilage repair therapy, including completion of the...
Cerapedics completed a US $11MM Series D financing to support expanded commercialization of i-FACTOR™ Peptide Enhanced Bone Graft....
Spineart secured a 30MM (~US $33MM) investment. Proceeds will support sales, geographical expansion in markets such as the U.S. and Europe and...
Histogenics seeks to raise ~US $30.0MM in a private placement. Net proceeds will support development of NeoCart® cartilage repair therapy,...
Lattice Biologics closed a private placement for gross proceeds of up to US $0.75MM to fund M&A and the acquisition of donors...
Tamiami Angel Fund II invested US $0.9MM in Catalyst OrthoScience, developer of a shoulder resurfacing system. ...
Rotation Medical completed a US $12MM Series B extension financing. Proceeds will support U.S. commercialization of its rotator cuff repair system, comprising...
Medtronic completed the second tranche of equity investment in Mazor Robotics, as laid out in a previously-executed agreement. ...
Medicrea entered into agreements to raise €20MM (~US $22.4MM) to support commercialization of UNiD™ Patient-Specific Rods in the U.S. and new ex-U.S....
Bioventus is reported to have delayed its US $150MM initial public offering. ...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.